Results 61 to 70 of about 11,635 (130)

The effect of surface charge on nonspecific uptake and cytotoxicity of CdSe/ZnS core/shell quantum dots

Beilstein Journal of Nanotechnology, 2015
In this work, cytotoxicity and cellular impedance response was compared for CdSe/ZnS core/shell quantum dots (QDs) with positively charged cysteamine–QDs, negatively charged dihydrolipoic acid–QDs and zwitterionic D-penicillamine–QDs exposed to canine ...
Vladimir V. Breus, Anna Pietuch, Marco Tarantola, Thomas Basché, Andreas Janshoff   +4 more
doaj   +1 more source

WILSON'S DISEASE IN CHILDREN, REPORT OF 25 CASES [PDF]

Acta Medica Iranica, 1984
We conducted a retrospective study of 25 cases (15 boys and 12 girls) of Wilson's disease(Hepatolenticular degeneration)spanning a period of 8 years. Age at the time of diagnosis ranged between 3-17 years. The f ollowing clinical forms were observed:
Y. AGHIGHI, R. AFTENDELIANS
doaj  

Evaluation of vitamin B₆ supplementation in Wilson's disease patients treated with D-penicillamine. [PDF]

BMJ Open Gastroenterol, 2023
Mbala J, Belmalih A, Guillaud O, Lachaux A, Couchonnal Bedoya E.   +4 more
europepmc   +1 more source

Post-marketing safety signals of Wilson’s disease therapies: evidence from FAERS and VigiBase

Orphanet Journal of Rare Diseases
Introduction Wilson’s disease is a rare autosomal copper metabolism recessive disorder that requires lifelong pharmacological treatment. D-penicillamine and trientine are the most commonly used copper chelators.
Hülya Tezel-Yalçın, Nadir Yalçın, Karel Allegaert, Pınar Erkekoğlu   +3 more
doaj   +1 more source

A rare case of DIC in a patient with Wilson's disease: D-penicillamine. [PDF]

Hepatol Forum, 2022
Emre Parlar Y, Yasemin Balaban H, Yavuz Malkan U, Deniz E, Rukiye Uysal F.   +4 more
europepmc   +1 more source

Non-ceruloplasmin copper and urinary copper in clinically stable Wilson disease: Alignment with recommended targets

JHEP Reports
Background & Aims: Wilson disease (WD) is caused by accumulation of copper primarily in the liver and brain. During maintenance therapy of WD with D-penicillamine, current guidelines recommend on-treatment ranges of urinary copper excretion (UCE) of ...
Peter Ott, Thomas Sandahl, Aftab Ala, David Cassiman, Eduardo Couchonnal-Bedoya, Rubens Gisbert Cury, Anna Czlonkowska, Gerald Denk, Renata D’Inca, Francisco de Assis Aquino Gondim, Joanna Moore, Aurelia Poujois, Carlos Alexandre Twardowschy, Karl Heinz Weiss, Massimo Zuin, C.Omar F. Kamlin, Michael L. Schilsky   +16 more
doaj   +1 more source

D-Penicillamine-Induced Myasthenia Gravis-A Probable Complication of Wilson's Disease Treatment-A Case Report and Systematic Review of the Literature. [PDF]

Life (Basel), 2023
Antos A, Członkowska A, Bembenek J, Kurkowska-Jastrzębska I, Litwin T.   +4 more
europepmc   +1 more source

Metabolic balances of sulfur in patients with hepatolenticular degeneration and effect of the use of D-penicillamine Balanços metabólicos do enxôfre em pacientes com degeneração hepatolenticular e efeito da administração de D-penicilamina

Arquivos de Neuro-Psiquiatria, 1969
The metabolic balances of sulfur in two cases of hepatolenticular degeneration were studied. A positive balance was found in both cases; in one patient submitted to mixed diet, the average was significantly higher than the normal mean. The administration
Horacio M. Canelas, Francisco B. De Jorge, Waldir A. Tognola   +2 more
doaj  

Comparative management practices of Wilson disease in Californian and Italian providers

Journal of Health, Population and Nutrition
Background There is a scarcity of randomized and high-quality studies to aid clinicians in management and treatment of Wilson disease (WD). Even amongst society practice guidelines in North America and Europe, diagnosis and management of WD varies.
Sandy Vien, Colin McNamara, Ronald Hsu, Massimo Zuin, Valentina Medici   +4 more
doaj   +1 more source

Fe-containing metal-organic framework with D-penicillamine for cancer-specific hydrogen peroxide generation and enhanced chemodynamic therapy. [PDF]

Bioeng Transl Med, 2023
Ji HB, Kim CR, Min CH, Han JH, Kim SN, Lee C, Choy YB.   +6 more
europepmc   +1 more source